Enhanced hepatocarcinogenesis in acatalasemic mice treated with diethylnitrosamine

Da Hong Wang, Yuka Funamori, Satoru Ikeda, Masaki Sato, Shohei Kira, Kazuhisa Taketa

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Diethylnitrosamine (DEN)-induced hepatocellular carcinogenesis was compared between C3H/AnLC(s)/(b)C(s)/(b) (acatalasemic) and C3H/AnLC(s)/(a)C(s)/(a) (normal) mice. A total of 31 normal and 38 acatalasemic male mice, average age 9 weeks, received a single intraperitoneal injection of DEN (75 mg/kg body wt) weekly for 6 weeks. All animals that survived until the end of week 31 (25th week after the last injection of DEN)were sacrificed and the development of liver tumors was found. They grossly varied from one to multiple in number and from i to 15 mm in diameter in both groups. The numbers and size of liver tumors per liver were significantly greater (P < 0.05) in acatalasemic mice (mean ± S.D.: 3.8 ± 2.0 in number per liver; 9.6 ± 7.4 in mm diameter per liver) than in normal mice (1.8 ± 1.1 in number per liver; 2.8 ± 1.9 in mm diameter per liver). Histological examination of the tumor tissues revealed the development of well-differentiated hepatocellular carcinomas. We suggest that H2O2 or ·OH formed from H2O2 is likely to be involved in DEN-induced hepatocarcinogenesis and catalase plays a critical role in the prevention of hepatocarcinogenesis.

Original languageEnglish
Pages (from-to)217-224
Number of pages8
JournalHepatology Research
Volume12
Issue number3
Publication statusPublished - Oct 1 1998

Keywords

  • Acatalasemic mice
  • Catalase
  • Diethylnitrosamine (DEN)
  • Hepatocarcinogenesis
  • Hydrogen peroxide
  • Hydroxyl radical

ASJC Scopus subject areas

  • Hepatology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Enhanced hepatocarcinogenesis in acatalasemic mice treated with diethylnitrosamine'. Together they form a unique fingerprint.

  • Cite this

    Wang, D. H., Funamori, Y., Ikeda, S., Sato, M., Kira, S., & Taketa, K. (1998). Enhanced hepatocarcinogenesis in acatalasemic mice treated with diethylnitrosamine. Hepatology Research, 12(3), 217-224.